Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus

BMC Cancer

Volumn 1, Issue , 2001, Pages

  Heise, Joachim W ^a   Heep, Hansjörg ^a   Frieling, Thomas ^a   Sarbia, Mario ^a   Hartmann, Karl A ^a   Röher, Hans Dietrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT; EPIRUBICIN; FLEP PROTOCOL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORBIDITY; ONCOLOGICAL PARAMETERS; REIMBURSEMENT; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; ADJUVANT THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DRUG THERAPY; ECONOMICS; ESOPHAGUS TUMOR; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; RADIATION DOSE; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DRUG THERAPY; EPIRUBICIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 18744406055     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-1-20     Document Type: Article

References (29)

1. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S: Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988, 96:242-248
2. Kelsen DP, Minsky B, Smith M, Beitler J, Niedzwiecki D, Chapman D, Bains M, Burt M, Heelan R, Hilaris B: Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. J Clin Oncol 1990, 8:1352-1361
3. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, Boutin D, Campion JP, Launois B: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994, 73:1779-1784
4. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, Sahmoud T: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997, 337:161-167
5. Law S, Fok M, Chow S, Chu KM, Wong J: Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997, 114:210-217
6. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998, 339:1979-1984
7. Tabira Y, Okuma T, Kondo K, Yoshioka M, Mori T, Tanaka M, Nakano K, Kitamura N: Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity? Jpn J Thorac Cardiovasc Surg 1999, 47:361-367
8. Schlag PM: Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992, 127:1446-1450
9. Hermanek P, Sobin LH: UICC, International Union against Cancer. TNM classification of malignant tumors. 4th fully revised ed.. Berlin- Heidelberg-New York-London-Paris-Tokyo: Springer-Verlag 1997
10. Stahl M, Wilke H, Fink U, Stuschke M, Walz MK, Siewert JR, Molls M, Fett W, Makoski HB, Breuer N, Schmidt U, Niebel W, Sack H, Eigler FW, Seeber S: Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 1996, 14:829-837
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481
12. MŸller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H: Surgical therapy of oesophageal carcinoma. Br J Surg 1990, 77:845-857
13. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR: Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994, 81:410-413
14. Horstmann O, Verreet PR, Becker H, Ohmann C, Roher HD: Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer. Eur J Surg 1995, 161:557-567
15. Vogel SB, Mendenhall WM, Sombeck MD, Marsh R, Woodward ER: Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995, 221:685-693
16. Lehnert T: Multimodal therapy for squamous carcinoma of the oesophagus. Br J Surg 1999, 86:727-739
17. Geh JI, Crellin AM, Glynne-Jones R: Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001, 88:338-356
18. Swisher SG, Holmes EC, Hunt KK, Doty JE, Zinner MJ, McFadden DW: The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg 1996, 131:819-824
19. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996, 335:462-467
20. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE: Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996, 14:156-163
21. Tsujinaka T, Shiozaki H, Yamamoto M, Inoue M, Yano M, Doki Y, Monden M: Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma. Am J Surg 1999, 177:503-506
22. Ishida K, Koeda K, Sato N, Ikeda K, Ohtsuka K, Aoki K, Kimura Y, Iwaya T, Uesugi N, Nakamura R: Problems in neoadjuvant chemoradiotherapy preceding surgery for advanced squamous cell carcinoma of the thoracic esophagus. Jpn J Thorac Cardiovasc 1999, 47:262-266
23. O'sullivan GC, Sheehan D, Clarke A, Stuart R, Kelly J, Kiely MD, Walsh T, Collins JK, Shanahan F: Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 1999, 116:543-548
24. van Lanschot JJ, Tilanus HW, Voormolen MH, van Deelen RA: Recurrence pattern of oesophageal carcinoma after limited resection does not support wide local excision with extensive lymph node dissection. Br J Surg 1994, 81:1320-1323
25. Law SY, Fok M, Wong J: Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 1996, 83:107-111
26. Laterza E, de'Manzoni G, Tedesco P, Guglielmi A, Verlato G, Cordiano C: Induction chemo-radiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase II study. Ann Surg Oncol 1999, 6:777-784
27. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A: Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal sqamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001, 91:2165-2174
28. Mallery S, DeCamp M, Bueno R, Mentzer SJ, Sugarbaker DJ, Swanson SJ, Van Dam J: Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma. Cancer 1999, 86:764-769
29. Tamim WZ, Davidson RS, Quinlan RM, O'Shea MA, Orr RK, Swanson RS: Neoadjuvant chemoradiotherapy for esophageal cancer: is it worthwhile? Arch Surg 1999, 133:722-726